CliffBio
small molecule

ISENTRESS HD

RALTEGRAVIR POTASSIUM

Loss of exclusivityMarch 2032latest FDA-listed patent expiry
CompanyMERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC

Drug detail

Brand nameISENTRESS HD
Active ingredientRALTEGRAVIR POTASSIUM
StrengthEQ 600MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusRX

Listed patents

PatentExpiresType
10772888March 2032use U-1663
9649311*PEDApril 2031—
9649311October 2030product
8771733June 2030substance, product
7754731*PEDSeptember 2029—
7754731March 2029substance, product

More from MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.